News
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
Comedian and Emmy-nominated actor Kym Whitley opens up about her long journey with weight management. The "Happy Gilmore 2" ...
FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs. But the drugs can leave some ...
CagriSema vs placebo was associated with significant weight loss among adults with overweight or obesity with or without type 2 diabetes.
DehydraTECH-semaglutide reduces overall side effects by 36.5% as compared to Rybelsus®DehydraTECH-semaglutide reduces gastrointestinal side effects by 43.5% as compared to Rybelsus®DehydraTECH-GLP-1 s ...
Celcuity said on Monday its experimental combination treatment delayed the progression of a type of advanced breast cancer in a late-stage study, sending the biotech firm's shares surging to a record ...
Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes ...
Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results